These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2110042

  • 1. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC, Bennett JP.
    Brain Res Dev Brain Res; 1990 Mar 01; 52(1-2):273-7. PubMed ID: 2110042
    [Abstract] [Full Text] [Related]

  • 2. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers.
    Broaddus WC, Bennett JP.
    Brain Res Dev Brain Res; 1990 Mar 01; 52(1-2):265-71. PubMed ID: 2331795
    [Abstract] [Full Text] [Related]

  • 3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 01; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 4. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 5. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J, Lindqvist E, Young D, Cowburn R.
    Exp Brain Res; 1990 Jul 07; 83(1):85-95. PubMed ID: 1981564
    [Abstract] [Full Text] [Related]

  • 6. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.
    Filloux F, Dawson TM, Wamsley JK.
    Brain Res Bull; 1988 Apr 07; 20(4):447-59. PubMed ID: 3135077
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS, Joyce JN.
    Brain Res Dev Brain Res; 1991 Jun 21; 60(2):105-13. PubMed ID: 1832593
    [Abstract] [Full Text] [Related]

  • 8. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 9. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution.
    Caboche J, Rogard M, Besson MJ.
    Brain Res Dev Brain Res; 1991 Jan 15; 58(1):111-22. PubMed ID: 1849802
    [Abstract] [Full Text] [Related]

  • 10. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O, De Montis G, Porceddu ML, Mele S, Calderini G, Toffano G, Biggio G.
    Brain Res; 1987 Oct 15; 432(2):283-90. PubMed ID: 2960426
    [Abstract] [Full Text] [Related]

  • 11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 15; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 12. Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats.
    Gong L, Kostrzewa RM, Li C.
    J Neurochem; 1994 Oct 15; 63(4):1282-90. PubMed ID: 7931280
    [Abstract] [Full Text] [Related]

  • 13. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS, Joyce JN.
    Synapse; 1992 May 15; 11(1):35-46. PubMed ID: 1351321
    [Abstract] [Full Text] [Related]

  • 14. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D, Trovero F, Blanc G, Glowinski J, Tassin JP.
    Neuroscience; 1992 May 15; 46(3):687-700. PubMed ID: 1532052
    [Abstract] [Full Text] [Related]

  • 15. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ, Marshall JF.
    Neuroscience; 1991 May 15; 41(2-3):473-81. PubMed ID: 1678501
    [Abstract] [Full Text] [Related]

  • 16. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ, Marshall JF.
    Brain Res; 1989 Nov 20; 502(2):223-32. PubMed ID: 2531015
    [Abstract] [Full Text] [Related]

  • 17. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M.
    J Neurochem; 1987 Oct 20; 49(4):1042-9. PubMed ID: 2957468
    [Abstract] [Full Text] [Related]

  • 18. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
    Olianas MC, Onali P.
    Neurosci Lett; 1987 Aug 05; 78(3):349-54. PubMed ID: 2819791
    [Abstract] [Full Text] [Related]

  • 19. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN.
    Exp Neurol; 1991 Sep 05; 113(3):277-90. PubMed ID: 1833220
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.